Cargando…
Hyper IgE recurrent infection syndrome in South Asia: is there a different outcome?
BACKGROUND: Hyper IgE recurrent infection syndrome (HIES) is a rare immune deficiency, characterized by recurrent staphylococcal skin and lung abscesses, pneumonia and increased IgE levels. The majority of autosomal dominant HIES (AD HIGE) is due to hypomorphic mutations in the signal transducer and...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214173/ https://www.ncbi.nlm.nih.gov/pubmed/30410549 http://dx.doi.org/10.1186/s13223-018-0292-3 |
_version_ | 1783367938649096192 |
---|---|
author | de Silva, Rajiva Dasanayake, Dhanushka Senanayake, Manouri Ediriweera, Ramya Dias, Savithri Karunatilleke, Chandima Brocas, Karen Tahami, Fariba Seneviratne, Suranjith |
author_facet | de Silva, Rajiva Dasanayake, Dhanushka Senanayake, Manouri Ediriweera, Ramya Dias, Savithri Karunatilleke, Chandima Brocas, Karen Tahami, Fariba Seneviratne, Suranjith |
author_sort | de Silva, Rajiva |
collection | PubMed |
description | BACKGROUND: Hyper IgE recurrent infection syndrome (HIES) is a rare immune deficiency, characterized by recurrent staphylococcal skin and lung abscesses, pneumonia and increased IgE levels. The majority of autosomal dominant HIES (AD HIGE) is due to hypomorphic mutations in the signal transducer and the activator of transcription 3 (STAT3) gene. CASE PRESENTATION: Five patients were diagnosed with HIES, based on the clinical criteria and scoring system developed at the National Institutes of Health (NIH), USA. The STAT3 gene was sequenced and previously described mutations were identified in all five patients. We compare the clinical features of our patients with those from Asia, Europe and the US. CONCLUSION: Even though the number of patients is limited, there are some clinical differences in patients from South Asia compared to European and even East Asian patients. However, the mutations detected are located at hot spots seen in western and Asian patients with AD HIGE. |
format | Online Article Text |
id | pubmed-6214173 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-62141732018-11-08 Hyper IgE recurrent infection syndrome in South Asia: is there a different outcome? de Silva, Rajiva Dasanayake, Dhanushka Senanayake, Manouri Ediriweera, Ramya Dias, Savithri Karunatilleke, Chandima Brocas, Karen Tahami, Fariba Seneviratne, Suranjith Allergy Asthma Clin Immunol Case Report BACKGROUND: Hyper IgE recurrent infection syndrome (HIES) is a rare immune deficiency, characterized by recurrent staphylococcal skin and lung abscesses, pneumonia and increased IgE levels. The majority of autosomal dominant HIES (AD HIGE) is due to hypomorphic mutations in the signal transducer and the activator of transcription 3 (STAT3) gene. CASE PRESENTATION: Five patients were diagnosed with HIES, based on the clinical criteria and scoring system developed at the National Institutes of Health (NIH), USA. The STAT3 gene was sequenced and previously described mutations were identified in all five patients. We compare the clinical features of our patients with those from Asia, Europe and the US. CONCLUSION: Even though the number of patients is limited, there are some clinical differences in patients from South Asia compared to European and even East Asian patients. However, the mutations detected are located at hot spots seen in western and Asian patients with AD HIGE. BioMed Central 2018-11-02 /pmc/articles/PMC6214173/ /pubmed/30410549 http://dx.doi.org/10.1186/s13223-018-0292-3 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Case Report de Silva, Rajiva Dasanayake, Dhanushka Senanayake, Manouri Ediriweera, Ramya Dias, Savithri Karunatilleke, Chandima Brocas, Karen Tahami, Fariba Seneviratne, Suranjith Hyper IgE recurrent infection syndrome in South Asia: is there a different outcome? |
title | Hyper IgE recurrent infection syndrome in South Asia: is there a different outcome? |
title_full | Hyper IgE recurrent infection syndrome in South Asia: is there a different outcome? |
title_fullStr | Hyper IgE recurrent infection syndrome in South Asia: is there a different outcome? |
title_full_unstemmed | Hyper IgE recurrent infection syndrome in South Asia: is there a different outcome? |
title_short | Hyper IgE recurrent infection syndrome in South Asia: is there a different outcome? |
title_sort | hyper ige recurrent infection syndrome in south asia: is there a different outcome? |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214173/ https://www.ncbi.nlm.nih.gov/pubmed/30410549 http://dx.doi.org/10.1186/s13223-018-0292-3 |
work_keys_str_mv | AT desilvarajiva hyperigerecurrentinfectionsyndromeinsouthasiaisthereadifferentoutcome AT dasanayakedhanushka hyperigerecurrentinfectionsyndromeinsouthasiaisthereadifferentoutcome AT senanayakemanouri hyperigerecurrentinfectionsyndromeinsouthasiaisthereadifferentoutcome AT ediriweeraramya hyperigerecurrentinfectionsyndromeinsouthasiaisthereadifferentoutcome AT diassavithri hyperigerecurrentinfectionsyndromeinsouthasiaisthereadifferentoutcome AT karunatillekechandima hyperigerecurrentinfectionsyndromeinsouthasiaisthereadifferentoutcome AT brocaskaren hyperigerecurrentinfectionsyndromeinsouthasiaisthereadifferentoutcome AT tahamifariba hyperigerecurrentinfectionsyndromeinsouthasiaisthereadifferentoutcome AT seneviratnesuranjith hyperigerecurrentinfectionsyndromeinsouthasiaisthereadifferentoutcome |